Home/Healthcare/Drug Pipeline/Computer-Aided Drug Discovery Market

Computer-Aided Drug Discovery Market - Strategic Insights and Forecasts (2025-2030)

Market Size, Growth, Forecast & Industry Analysis By Type (Structure-Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories), and Geography

Market Size in 2025
USD 5.96 billion
Market Size in 2030
USD 10.31 billion
CAGR
11.59%
Study Period
2020-2030
$3,950
Single User License
Access Full Insights
Download Free Sample
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Navigate

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061617235
PublishedJan 2026
Pages140
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The computer-aided drug discovery market is expected to reach a total market size of US$10.31 billion by 2030.

Computer-Aided Drug Discovery Market is valued at US$5.96 billion in 2025.

The global computer-aided drug discovery market is expected to grow at a CAGR of 11.59% during the forecast period.

The computer-aided drug discovery market is driven by AI integration, increased NCDs, personalized medicine, and rapid drug development innovations.

The Asia-Pacific region is anticipated to hold a significant share of the computer-aided drug discovery market.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon